1. Home
  2. COHU vs ZYME Comparison

COHU vs ZYME Comparison

Compare COHU & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COHU
  • ZYME
  • Stock Information
  • Founded
  • COHU 1947
  • ZYME 2003
  • Country
  • COHU United States
  • ZYME United States
  • Employees
  • COHU N/A
  • ZYME N/A
  • Industry
  • COHU Electrical Products
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • COHU Industrials
  • ZYME Health Care
  • Exchange
  • COHU Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • COHU 885.9M
  • ZYME 968.5M
  • IPO Year
  • COHU N/A
  • ZYME 2017
  • Fundamental
  • Price
  • COHU $20.86
  • ZYME $14.35
  • Analyst Decision
  • COHU Buy
  • ZYME Buy
  • Analyst Count
  • COHU 6
  • ZYME 7
  • Target Price
  • COHU $28.20
  • ZYME $20.00
  • AVG Volume (30 Days)
  • COHU 411.6K
  • ZYME 427.2K
  • Earning Date
  • COHU 07-31-2025
  • ZYME 08-07-2025
  • Dividend Yield
  • COHU N/A
  • ZYME N/A
  • EPS Growth
  • COHU N/A
  • ZYME N/A
  • EPS
  • COHU N/A
  • ZYME N/A
  • Revenue
  • COHU $393,941,000.00
  • ZYME $122,867,000.00
  • Revenue This Year
  • COHU $10.84
  • ZYME $44.71
  • Revenue Next Year
  • COHU $14.84
  • ZYME $34.57
  • P/E Ratio
  • COHU N/A
  • ZYME N/A
  • Revenue Growth
  • COHU N/A
  • ZYME 95.94
  • 52 Week Low
  • COHU $12.57
  • ZYME $9.03
  • 52 Week High
  • COHU $29.42
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • COHU 58.78
  • ZYME 61.41
  • Support Level
  • COHU $18.92
  • ZYME $11.51
  • Resistance Level
  • COHU $21.36
  • ZYME $14.05
  • Average True Range (ATR)
  • COHU 0.82
  • ZYME 0.61
  • MACD
  • COHU 0.19
  • ZYME 0.07
  • Stochastic Oscillator
  • COHU 79.78
  • ZYME 94.88

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: